Cargando…
Burkitt lymphoma in adolescents and young adults: management challenges
About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-third belong to the adolescent and young adult (AYA) subset, defined by an age between 15 and 25–40 years, based on selection criteria used in different reports. BL is an aggressive B-cell neoplasm displaying hig...
Autores principales: | Dozzo, Massimo, Carobolante, Francesca, Donisi, Pietro Maria, Scattolin, Annamaria, Maino, Elena, Sancetta, Rosaria, Viero, Piera, Bassan, Renato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207020/ https://www.ncbi.nlm.nih.gov/pubmed/28096698 http://dx.doi.org/10.2147/AHMT.S94170 |
Ejemplares similares
-
Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
por: Maino, Elena, et al.
Publicado: (2015) -
Practical guidance for the management of acute lymphoblastic leukemia
in the adolescent and young adult population
por: Carobolante, Francesca, et al.
Publicado: (2020) -
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
por: Tosi, Manuela, et al.
Publicado: (2021) -
Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-Negative Adult Acute Lymphoblastic Leukemia
por: Spinelli, Orietta, et al.
Publicado: (2014) -
Burkitt Lymphoma of Thyroid Gland in an Adolescent
por: Cooper, K., et al.
Publicado: (2014)